Skip to main content
. 2022 Aug;11(8):1526–1539. doi: 10.21037/tlcr-22-192

Figure 3.

Figure 3

KM analysis for OS of a homogenous patient cohort of 100 NSCLC patients with pTNM I–III according to SS-p16, SS-p21 and SS-p16-p21. pTNM, pathological tumor-node-metastasis; SS, senescence signature; OS, overall survival; KM, Kaplan-Meier; NSCLC, non-small cell lung cancer.